Group One Trading
MRVI icon

Group One Trading’s Maravai LifeSciences MRVI Stock Holding History

Group One Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.3K Buy
+9,653
New +$32.7K ﹤0.01% 5746
2025
Q2 		– Sell
-15,813
Closed -$33.2K – 8382
2025
Q1 		$34.9K Buy
+15,813
New +$62.5K ﹤0.01% 5439
2024
Q4 		– Sell
-21,727
Closed -$140K – 7707
2024
Q3 		$181K Buy
+21,727
New +$188K ﹤0.01% 3710
2024
Q2 		– Sell
-7,723
Closed -$66.7K – 7197
2024
Q1 		$67K Buy
7,723
+664
+9% +$4.49K ﹤0.01% 4467
2023
Q4 		$46.2K Sell
7,059
-20,388
-74% -$132K ﹤0.01% 5121
2023
Q3 		$274K Sell
27,447
-127,250
-82% -$1.4M ﹤0.01% 3520
2023
Q2 		$1.92M Buy
154,697
+142,634
+1,182% +$1.93M 0.01% 1744
2023
Q1 		$169K Buy
12,063
+4,735
+65% +$68K ﹤0.01% 3816
2022
Q4 		$105K Buy
7,328
+4,097
+127% +$64.5K ﹤0.01% 4402
2022
Q3 		$82K Sell
3,231
-8,525
-73% -$214K ﹤0.01% 4956
2022
Q2 		$334K Buy
+11,756
New +$372K ﹤0.01% 3810

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's MRVI Position: Q1 2026 in Review

Group One Trading opened a new position in Maravai LifeSciences (MRVI) in Q1 2026: 9,653 shares worth $27.3K. The stake represents ﹤0.01% of the portfolio and ranks #5746 among its holdings. This is a return to the name: Group One Trading previously reported a position in MRVI as recently as Q1 2025.

Group One Trading first reported a position in MRVI in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.92M in Q2 2023. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Group One Trading held 9,653 shares of Maravai LifeSciences worth $27.3K as of Q1 2026.
  • Maravai LifeSciences was a new Group One Trading position in Q1 2026.
  • Maravai LifeSciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5746 holding.
  • Group One Trading first reported a position in Maravai LifeSciences in Q2 2022 and has held it in 11 quarters since.
  • Group One Trading's Maravai LifeSciences position peaked at $1.92M in Q2 2023.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.